11th Annual Risk Management
and Pharmacovigilance
Summit

Event is Over

Stay Updated for 2025 edition

Past Speakers

SEE THE PREVIOUS SPEAKERS & CASE STUDIES

Слайдшоу

Bettina Wick-Urban

Senior Scientific Director Benefit Risk Management PV & PS

CASE STUDY

Assessment of Benefit-Risk During Clinical Development

Carla Mateo Mohedano

Associate Director, Patient Safety Scientist — Oncology

CASE STUDY

Unravelling the Complexity of Signal Detection and Risk Assessments on the Oncology Therapeutic Area

This presentation aims to emphasise the challenges of signal detection and risk assessments within the Oncology Therapeutic Area. In addition, it provides some useful insights on how to address some of the main challenges in this landscape.

Erika Barbarosie

Associate Director Compliance

CASE STUDY

The Pitfalls of the EU PSMF

Marcin Kruk

Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East

CASE STUDY

Future of Pharmacovigilance Systems — Lessons Learned From COVID-19 Pandemic

COVID-19 pandemic started in late 2019 in China, expanding worldwide rapidly in early 2020. It resulted in 7 mln deaths. It became a novel challenge to the pharmacovigilance system worldwide for the whole pharma industry, particularly those parties that introduced vaccines against COVID-19. The development of vaccines and the unprecedented volume of ISRs reported in a short period of time after mass vaccination programmes started resulted in various types of challenges that required new ways of managing data, risk, reporting, controls and application of new technologies. The pandemic provided lessons learned that impacted the future of effective pharmacovigilance systems.

Show More

Daniela Santos

Head Global Drug
Safety Hub

CASE STUDY

Innovations in Global Drug Safety: A Comprehensive Approach to Risk Management and Pharmacovigilance

Thumbnail 1
Thumbnail 2
Thumbnail 3
Thumbnail 4
Thumbnail 5
11

Bettina Wick-Urban

Senior Scientific Director Benefit Risk Management PV & PS

CASE STUDY

Assessment of Benefit-Risk During Clinical Development

22

Carla Mateo Mohedano

Associate Director, Patient Safety Scientist — Oncology

CASE STUDY

Unravelling the Complexity of Signal Detection and Risk Assessments on the Oncology Therapeutic Area

This presentation aims to emphasise the challenges of signal detection and risk assessments within the Oncology Therapeutic Area. In addition, it provides some useful insights on how to address some of the main challenges in this landscape.

44

Erika Barbarosie

Associate Director Compliance

CASE STUDY

The Pitfalls of the EU PSMF

7777

Marcin Kruk

Senior Director, Drug Safety Unit Regional Head, Europe, Africa & Middle East

CASE STUDY

Future of Pharmacovigilance Systems — Lessons Learned From COVID-19 Pandemic

COVID-19 pandemic started in late 2019 in China, expanding worldwide rapidly in early 2020. It resulted in 7 mln deaths. It became a novel challenge to the pharmacovigilance system worldwide for the whole pharma industry, particularly those parties that introduced vaccines against COVID-19. The development of vaccines and the unprecedented volume of ISRs reported in a short period of time after mass vaccination programmes started resulted in various types of challenges that required new ways of managing data, risk, reporting, controls and application of new technologies. The pandemic provided lessons learned that impacted the future of effective pharmacovigilance systems.

Show More
33

Daniela Santos

Head Global Drug
Safety Hub

CASE STUDY

Innovations in Global Drug Safety: A Comprehensive Approach to Risk Management and Pharmacovigilance

Ahmed Nasr

Operations Director Egypt and Director Milk Africa & Turkey

Khaled Elsharkawy

Integrated Supply Chain Senior Director

Mueen Uddin Siddique

Senior Director – Access Network Procurement

Shannon Hore

Senior Vice President Procurement and Logistics

Sandeep Sharma

Director Group Procurement & International Markets Supply Chain

Hottest topics

LOOK AT THE TOPICS THAT WERE DISCUSSED

Testimonials

What our users say about our conferences

Play Video
Very well organised summit packed with resourceful presentations. It was a fantastic conference!
Union National Bank
Chief Human Resources Officer
Great event, very good topics and discussions with diverse participants
Landmark Group
Head – Rewards & Organisational Effectiveness,
Good overall, I gain a lot of useful information. Lots of insights to learn from and a great speaker line-up.
Abu Dhabi Airports
Total Rewards Head, Senior Manager Organisation Development
Great conference. I really liked meeting the other participants and the opportunity to openly share insights.
Adidas
Director Compensation Programmes
Very relevant topics from everyday practicalities to more visionary. Experienced & knowledgeable speakers. I really liked the quality of topics and their usefulness.
Pfizer
Senior Director Safety Risk Lead
Very good conference with a friendly atmosphere and a panel of very good experts. Discussions were very lively and open.
Sanofi
Head of QPPV Office
Good event where pharma companies can exchange experience. I got a very good overview about the hot topics in PV and current needs and developments.
Vifor Pharma
Head Clinical Drug Safety
The right amount of participants allowing for good interaction between peers. Interesting topics with studies.
Takeda
Associate Director, PV Compliance

Sponsors

Our Trusted Sponsors at This Summit

STAY UPDATED FOR THE 2025 EDITION

Provide Us With Your Contact Details and Our Team Will Get Back to You
With All the Updates Regarding the Upcoming Edition of This Event.